Last edition
News about "Department of Pharmaceuticals (DoP)"
DoP Seeks Stakeholder Feedback on GTE Medical Device Exemption Amendments
The Department of Pharmaceuticals (DoP) has invited stakeholder comments on proposed amendments to the Global Tender Enquiry (GTE) exemption list for medical devices. Feedback can be submitted until July 15, 2026.
Department Of Pharmaceuticals (DoP) | 24/06/2026 | By News Bureau
India Poised to Become a Global Biopharma Leader: Anupriya Patel
Union Minister Anupriya Patel said India is well-positioned to become a global biopharma leader, highlighting the Biopharma SHAKTI initiative’s goal of launching 100 biologics by 2047. She urged the industry to strengthen capabilities in biologics and biosimilars.
Department Of Pharmaceuticals (DoP) | 12/06/2026 | By News Bureau | 103
PRIP Scheme to Boost Pharma MedTech R&D: Applications Open Now
The Department of Pharmaceuticals (DoP) has invited applications for the Promotion of Research and Innovation in Pharma MedTech sector (PRIP) scheme.
Department Of Pharmaceuticals (DoP | 03/10/2025 | By Dineshwori | 667
DoP extends timeline to apply for 11 bulk drugs under PLI scheme
The DoP invited applications from eligible manufacturers under the scheme on May 14, for products which have not been applied for or are partially produced under the scheme, by the industry.<br />
Department Of Pharmaceuticals (DoP) | 18/06/2025 | By Darshana | 448
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy